Thus, the intracellular concentration of the drug is reduced to subtherapeutic levels due to P-gp activity before the drug can fulfil its mission within the tumor cells, thereby reducing the efficacy of chemotherapy in cancer treatment [4]. Here, PGP is linked to neoplasm.